Surmodics Shares Data From 160 Patients In PROWL Registry Using Pounce For Real-World Limb Ischemia

Reuters
Nov 20, 2025
Nov 4 (Reuters) - Surmodics Inc ::
*SURMODICS ANNOUNCES OUTCOMES FROM 160 PATIENTS IN PROWL REGISTRY EVALUATING POUNCE™ THROMBECTOMY PLATFORM IN TREATMENT OF REAL-WORLD LIMB ISCHEMIA PRESENTATIONS
*SURMODICS INC - PROCEDURAL SUCCESS 91.7%, DEVICE-RELATED ADVERSE EVENTS 0.6%
*SURMODICS INC - 94.8% PATIENTS EXPERIENCED POST-PROCEDURAL BLOOD FLOW RESTORATION
*SURMODICS INC - DEVICE TECHNICAL SUCCESS 83.2% WITH <50% RESIDUAL OBSTRUCTION

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 04-NOV-202511:15:00.15 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10